Skip to Content

Lexaria Bioscience Corp LEXX

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Lexaria Bioscience Corp is a food science company. The company's food sciences activities include the development of the proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under two consumer product brands, ViPova and Lexaria Energy. The company's patented lipid nutrient infusion technology DehydraTECHTM is believed to improve taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins NSAIDs Nicotine, and other molecules. Its operating segment includes Intellectual Property Licensing and Consumer Products. The company generates maximum revenue from Intellectual Property Licensing segment.

Contact
740 McCurdy Road, Suite 100
Kelowna, BC, V1X 2P7
T +1 250 765-6424
Sector Consumer Defensive
Industry Packaged Foods
Most Recent Earnings Nov 30, 2020
Fiscal Year End Aug 31, 2021
Stock Type Speculative Growth
Employees 6